CSIMarket
 


Otonomy Inc   (OTIC)
Other Ticker:  
 

Otonomy Inc 's Total Debt to Equity

OTIC's quarterly Total Debt to Equity and Total Debt, Equity growth


Due to net new borrowings of 0.29%, Total Debt to Equity fell to 0.75, a new company high.

Within Major Pharmaceutical Preparations industry in the third quarter 2022, 125 other companies have achieved lower Total Debt to Equity than Otonomy Inc in the III Quarter 2022. While Total Debt to Equity total ranking has improved so far in the third quarter 2022 to 1841, from total ranking in the second quarter 2022 at 1887 .

Explain Debt to Equity Ratio?
What is the structure of OTIC´s Total Debt?
How valuable is the OTIC´s Equity?


OTIC Total Debt to Equity (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change -67.84 % -58.69 % -22.8 % -17.14 % -11.43 %
Y / Y Total Debt Change 1.1 % 1.07 % 5.51 % 5.54 % 5.56 %
Total Debt to Equity MRQ 0.75 0.5 0.37 0.29 0.24
OTIC's Total Ranking # 1841 # 1887 # 1417 # 1261 # 907
Seq. Equity Change -33.29 % -25.83 % -21.23 % -17.48 % -14.31 %
Seq. Total Debt Change 0.29 % 0.27 % 0.27 % 0.26 % 0.26 %



Total Debt to Equity third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 126
Healthcare Sector # 324
Overall Market # 1841


Total Debt to Equity Statistics
High Average Low
0.75 0.35 0.19
(Sep 30 2022)   (Dec 31 2018)




Financial Statements
Otonomy Inc 's Equity $ 21 Millions Visit OTIC's Balance sheet
Otonomy Inc 's Total Debt $ 16 Millions Visit OTIC's Balance sheet
Source of OTIC's Sales Visit OTIC's Sales by Geography


Cumulative Otonomy Inc 's Total Debt to Equity

OTIC's Total Debt to Equity for the trailling 12 Months

OTIC Total Debt to Equity

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity TTM Growth -67.84 % -58.69 % -22.8 % -17.14 % -11.43 %
Y / Y Total Debt TTM Growth 1.1 % 1.07 % 5.51 % 5.54 % 5.56 %
Total Debt to Equity TTM 0.42 0.33 0.26 0.25 0.23
Total Ranking TTM # 111 # 216 # 79 # 76 # 6
Seq. Equity TTM Growth -33.29 % -25.83 % -21.23 % -17.48 % -14.31 %
Seq. Total Debt TTM Growth 0.29 % 0.27 % 0.27 % 0.26 % 0.26 %


On the trailing twelve months basis Due to the net new borrowings of 0.29% during the trailing twelve months finishing in the III Quarter 2022, cumulativeTotal Debt to Equity improved to 0.42, above the Otonomy Inc 's average Total Debt to Equity.
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 19, during the past 12 months, other companies have achieved lower Total Debt to Equity than Otonomy Inc . While Total Debt to Equity total ranking has improved so far to 111, from total ranking in previous 12 month period at 216.

Explain Debt to Equity Ratio?
What is the structure of OTIC´s Total Debt?
How valuable is the OTIC´s Equity?

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 20
Healthcare Sector # 39
Within the Market # 111


trailing twelve months Total Debt to Equity Statistics
High Average Low
0.43 0.26 0.04
(Jun 30 2020)   (Dec 31 2018)




Companies with similar Total Debt to Equity in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Total Debt to EquitySep 30 2022 MRQ Total DebtSep 30 2022 MRQ Equity
Athenex Inc   2.06 $ 14.927  Millions$ 7.236  Millions
Scynexis Inc   1.99 $ 34.162  Millions$ 17.209  Millions
Morphosys Ag  1.85 $ 326.645  Millions$ 176.299  Millions
Ascendis Pharma A  1.83 $ 540.911  Millions$ 294.950  Millions
Phibro Animal Health Corporation  1.78 $ 467.158  Millions$ 262.756  Millions
G1 Therapeutics Inc   1.67 $ 76.558  Millions$ 45.965  Millions
Mallinckrodt Plc  1.66 $ 3,078.400  Millions$ 1,849.100  Millions
China Pharma Holdings Inc   1.60 $ 4.550  Millions$ 2.835  Millions
Eli Lilly And Company  1.56 $ 15,888.400  Millions$ 10,165.900  Millions
Zoetis Inc   1.41 $ 6,563.000  Millions$ 4,662.000  Millions
9 Meters Biopharma Inc   1.37 $ 18.390  Millions$ 13.461  Millions
Aveo Pharmaceuticals Inc   1.34 $ 38.678  Millions$ 28.845  Millions
Bristol myers Squibb Company  1.19 $ 39,098.000  Millions$ 32,734.000  Millions
Ocular Therapeutix Inc   1.15 $ 53.344  Millions$ 46.229  Millions
Adc Therapeutics Sa  1.10 $ 97.240  Millions$ 88.727  Millions
Chembio Diagnostics Inc   1.07 $ 18.994  Millions$ 17.793  Millions
Viatris Inc   1.04 $ 19,988.700  Millions$ 19,182.300  Millions
Lifecore Biomedical Inc   1.02 $ 98.569  Millions$ 96.899  Millions
Pacira Biosciences inc   0.97 $ 747.871  Millions$ 770.123  Millions
Neptune Wellness Solutions Inc   0.94 $ 14.692  Millions$ 15.596  Millions
Ani Pharmaceuticals Inc  0.92 $ 286.732  Millions$ 311.825  Millions
Evoke Pharma Inc   0.90 $ 5.000  Millions$ 5.533  Millions
Fortress Biotech Inc   0.90 $ 91.165  Millions$ 101.352  Millions
Catalent Inc   0.89 $ 4,204.000  Millions$ 4,700.000  Millions
Perrigo Company Plc  0.89 $ 4,111.000  Millions$ 4,602.700  Millions
Prestige Consumer Healthcare Inc   0.89 $ 1,438.338  Millions$ 1,619.841  Millions
Elanco Animal Health Inc  0.87 $ 5,901.000  Millions$ 6,745.000  Millions
Rockwell Medical inc   0.87 $ 14.093  Millions$ 16.136  Millions
Marinus Pharmaceuticals Inc   0.86 $ 70.780  Millions$ 82.004  Millions
Innoviva Inc   0.84 $ 539.810  Millions$ 641.368  Millions

Date modified: 2022-11-13T01:21:05+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com